Demand for special purpose needles will increase through 2036, with hypodermic needles at a 39.4% share, driven by widespread use across drug delivery, vaccination, and clinical sampling applications. Drug delivery leads with a 58.3% share. The market is set to reach USD 15.8 billion by 2026-end and USD 34.2 billion by 2036.